Department of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
School of Medicine, Ain Shams University, Cairo, 1156, Egypt.
Nature. 2013 May 9;497(7448):249-253. doi: 10.1038/nature12054. Epub 2013 Apr 17.
The neonatal mammalian heart is capable of substantial regeneration following injury through cardiomyocyte proliferation. However, this regenerative capacity is lost by postnatal day 7 and the mechanisms of cardiomyocyte cell cycle arrest remain unclear. The homeodomain transcription factor Meis1 is required for normal cardiac development but its role in cardiomyocytes is unknown. Here we identify Meis1 as a critical regulator of the cardiomyocyte cell cycle. Meis1 deletion in mouse cardiomyocytes was sufficient for extension of the postnatal proliferative window of cardiomyocytes, and for re-activation of cardiomyocyte mitosis in the adult heart with no deleterious effect on cardiac function. In contrast, overexpression of Meis1 in cardiomyocytes decreased neonatal myocyte proliferation and inhibited neonatal heart regeneration. Finally, we show that Meis1 is required for transcriptional activation of the synergistic CDK inhibitors p15, p16 and p21. These results identify Meis1 as a critical transcriptional regulator of cardiomyocyte proliferation and a potential therapeutic target for heart regeneration.
哺乳动物的新生心脏在受到损伤后,通过心肌细胞增殖,具有很强的再生能力。然而,这种再生能力在出生后第 7 天就会丧失,心肌细胞周期阻滞的机制仍不清楚。同源域转录因子 Meis1 是心脏正常发育所必需的,但它在心肌细胞中的作用尚不清楚。在这里,我们鉴定出 Meis1 是心肌细胞细胞周期的关键调节因子。在小鼠心肌细胞中删除 Meis1 足以延长心肌细胞的出生后增殖窗口,并在成年心脏中重新激活心肌细胞有丝分裂,而对心脏功能没有不良影响。相比之下,心肌细胞中 Meis1 的过表达会减少新生儿心肌细胞的增殖,并抑制新生儿心脏的再生。最后,我们表明 Meis1 是协同 CDK 抑制剂 p15、p16 和 p21 的转录激活所必需的。这些结果表明 Meis1 是心肌细胞增殖的关键转录调节因子,也是心脏再生的潜在治疗靶点。